Skip to content

Comparative clinical study of godanti-gairika vati and godanti-kasisa vati in pandu ( iron deficiency anaemia) and pharmaceutico-analytical study of these two vati.

A comparative pharmaceutico-analytical study of Godanti-Gairika vati & Godanti-Kasisa vati and its clinical effect in pandu roga w.s.r. to iron deficiency anaemia.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047470
Enrollment
30
Registered
2022-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Principal, R.G.G.P.G. Ayurvedic College and Hospital Paprola, Distt. Kangra, H.P.
Lead Sponsor
Prof Ashwani Upadhyaya
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for clinical trial and ready to give written consent. 2.Patients having Hb more than 8gm% but less than 10gm%. 3.Patients possessing sign and symptoms of Pandu roga on the basis of diagnostic criteria. 4.Patients not having any associated chronic ailment.

Exclusion criteria

Exclusion criteria: 1.Patients having Hb less than 8gm% or more than 10 gm %. 2.Patients with further complications of Pandu roga such as hridroga, shotha etc. 3.Congenital anaemia like sideroblastic anaemia, congenital dyserythropoetic anaemia, thalessemia, sickle cell anaemia, aplastic anaemia etc. 4.Patients having blood loss due to haemorrhoids, ulcers and epistaxis. 5.Patients suffering from AIDS, Cancer, TB, Diabetes mellitus or any other severe systemic dissorder.

Design outcomes

Primary

MeasureTime frame
Relieve in symptoms like palpitations, dryness, lack of sweating and fatigue, tinnitus, pallor, generalised weakness, vertigo, excessive sleep, pain in the calf muscle, swelling around the eye, anorexia.Timepoint: 45 days trial period

Secondary

MeasureTime frame
Complete remission of sign and symptoms. Improved haemoglobin levels of patients.Timepoint: Follow up 1 month after completion of trial

Countries

India

Contacts

Public ContactDr Manjeeta Ramol

Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital Paprola Kangra HP

drashwani1963@gmail.com9418186116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026